IMPACT OF DELAYED TREATMENT INITIATION WITH RESMETIROM IN PATIENTS WITH NONCIRRHOTIC NONALCOHOLIC STEATOHEPATITIS (NASH) WITH MODERATE TO ADVANCED FIBROSIS

被引：0
|
作者：
Ansaripour, A. [1 ]
Kim, Y. [2 ]
Montero, M. Gomez [1 ]
Hosmane, S. [2 ]
机构：
[1] Optimax Access, Rotterdam, ZH, Netherlands
[2] Madrigal Pharmaceut, Jersey City, NJ USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE511
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CURRENTLY AVAILABLE NONINVASIVE TESTS ACCURATELY STAGE FIBROSIS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH)
    Harrison, Stephen A.
    Lawitz, Eric J.
    Wong, Vincent Wai-Sun
    Anstee, Quentin M.
    Trauner, Michael H.
    Romero-Gomez, Manuel
    Bhandari, Bal
    Abdelmalek, Manal F.
    Sanyal, Arun J.
    Patel, Keyur
    Leroy, Vincent
    Bureau, Christophe
    Sasso, Magali
    Fournier, Celine D.
    Sandrin, Laurent
    Han, Ling
    Li, Georgia
    Kersey, Kathryn
    Camargo, Marianne
    Djedjos, Stephen
    Myers, Robert P.
    Goodman, Zackary
    Younossi, Youssef
    HEPATOLOGY, 2019, 70 : 1349A - 1350A
  • [22] Clinical and Histological Determinants of Nonalcoholic Steatohepatitis and Advanced Fibrosis in Elderly Patients
    Noureddin, Mazen
    Yates, Katherine P.
    Vaughn, Ivana A.
    Neuschwander-Tetri, Brent A.
    Sanyal, Arun J.
    McCullough, Arthur
    Merriman, Raphael
    Hameed, Bilal
    Doo, Edward
    Kleiner, David E.
    Behling, Cynthia
    Loomba, Rohit
    HEPATOLOGY, 2013, 58 (05) : 1644 - 1654
  • [23] Validation of Serum Test for Advanced Liver Fibrosis in Patients With Nonalcoholic Steatohepatitis
    Loomba, Rohit
    Jain, Anjali
    Diehl, Anna Mae
    Guy, Cynthia D.
    Portenier, Dana
    Sudan, Ranjan
    Singh, Seema
    Faulkner, Claire
    Richards, Lisa
    Hester, Kelly D.
    Okada, Lauren
    Li, Xiao-jun
    Mimms, Larry
    Abdelmalek, Manal F.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (09) : 1867 - +
  • [24] Correlations between hepatic morphometric collagen content, histologic fibrosis staging, and serum markers in patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH)
    Goodman, Zachary D.
    Alaparthi, Lakshmi
    Monge, Fanny
    Patel, Keyur
    Loomba, Rohit
    Caldwell, Stephen H.
    Lawitz, Eric
    Harrison, Stephen A.
    Shiffman, Mitchell L.
    Abdelmalek, Manal F.
    Myers, Robert P.
    Schall, Raul E. Aguilar
    Subramanian, Mani
    McHutchison, John G.
    Ratziu, Vlad
    Sanyal, Arun J.
    Afdhal, Nezam H.
    HEPATOLOGY, 2015, 62 : 906A - 906A
  • [25] Estimation of the Eligible Population For Resmetirom Among Adults in the United States for Treatment of Non-Cirrhotic NASH with Moderate-to-Advanced Liver Fibrosis
    Fishman, Jesse
    Kim, Yestle
    Charlton, Michael R.
    Smith, Zachary J.
    O'Connell, Tom
    Bercaw, Eric M.
    ADVANCES IN THERAPY, 2024, 41 (11) : 4172 - 4190
  • [26] Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes
    Younossi, Zobair M.
    Wong, Vincent Wai-Sun
    Anstee, Quentin M.
    Romero-Gomez, Manuel
    Trauner, Michael H.
    Harrison, Stephen A.
    Lawitz, Eric J.
    Okanoue, Takeshi
    Camargo, Marianne
    Kersey, Kathryn
    Myers, Robert P.
    Goodman, Zachary
    Stepanova, Maria
    HEPATOLOGY COMMUNICATIONS, 2020, 4 (11) : 1637 - 1650
  • [27] Targeting CCR2/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges
    Lefere, Sander
    Devisscher, Lindsey
    Tacke, Frank
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2020, 29 (02) : 89 - 92
  • [28] THE IMPACT OF TREATMENT-RELATED CHANGES IN LIPIDS ON THE COST-EFFECTIVENESS OF RESMETIROM AND OBETICHOLIC ACID FOR TREATMENT OF NONALCOHOLIC STEATOHEPATITIS
    Ansaripour, A.
    Fishman, J.
    Moloney, E.
    Javanbakht, M.
    VALUE IN HEALTH, 2023, 26 (06) : S100 - S101
  • [29] Advanced MRI of Liver Fibrosis and Treatment Response in a Rat Model of Nonalcoholic Steatohepatitis
    Zhou, Iris Y.
    Jordan, Veronica Clavijo
    Rotile, Nicholas J.
    Akam, Eman
    Krishnan, Smitha
    Arora, Gunisha
    Krishnan, Hema
    Slattery, Hannah
    Warner, Noah
    Mercaldo, Nathaniel
    Farrar, Christian T.
    Wellen, Jeremy
    Martinez, Robert
    Schlerman, Franklin
    Tanabe, Kenneth K.
    Fuchs, Bryan C.
    Caravan, Peter
    RADIOLOGY, 2020, 296 (01) : 67 - 75
  • [30] Orlistat Reverse Fatty Infiltration and Improves Hepatic Fibrosis in Obese Patients with Nonalcoholic Steatohepatitis (NASH)
    Osamah Hussein
    Masha Grosovski
    Sorina Schlesinger
    Sergio Szvalb
    Nimer Assy
    Digestive Diseases and Sciences, 2007, 52 : 2512 - 2519
12345